Trusted Resources: Education
Scientific literature and patient education texts
Mucopolysaccharidosis Patients Have Reduced Functional Capacity
source: Pediatric pulmonology
year: 2022
authors: Dias BMC,Lanza FC,Santos JD,Aranda CS,Solé D,Martins AM,Wandalsen GF
summary/abstract:Mucopolysaccharidoses (MPSs) are a group of rare diseases caused by an intralysosomal accumulation of glycosaminoglycans, resulting in a multisystemic clinical condition characterized by variable degrees of physical-functional impairment.
organization: Universidade Federal de São Paulo (EPM-UNIFESP), São Paulo, São Paulo, Brazil.DOI: 10.1002/ppul.25750
read more
BookmarkRelated Content
-
Genome Editing in Mucopolysaccharidoses and MucolipidosesMucopolysaccharidoses (MPS) and mucolipi...
-
Hyo-Mental Angle and Distance: An Important Adjunct in Airway Assessment of Adult MucopolysaccharidosisMucopolysaccharidosis (MPS) is a rare co...
-
The Experiences and Support Needs of Siblings of People With MucopolysaccharidosisThe mucopolysaccharidoses (MPS) are a gr...
-
A Rare Specialism: A Look at the Last Ten Years in MPS Management, Presented by Dr Christina Lampehttps://www.youtube.com/watch?v=EjNEVoWT...
-
Macular Changes in a Mucopolysaccharidosis Type I Patient With Earlier Systemic TherapiesTo describe retinal findings in a patien...
-
Mucopolysaccharidoses Type I Gene TherapyMucopolysaccharidoses type I (MPS I) is ...
-
International MPS NetworkCreated in April 1992 by Christine Laver...
Powered by
